NCT01141296View on ClinicalTrials.gov

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2011

Conditions
Primary Biliary Cirrhosis
Interventions
DRUG

fenofibrate

fenofibrate 200 mg PO daily for 1 year

DRUG

placebo

Placebo pill identical to active drug will be given PO once a day for 1 year

Trial Locations (2)

33136

University of Miami, Miami

55902

Mayo Clinic Rochester, Rochester

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

University of Miami

OTHER